{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:59:03Z","timestamp":1792432743369,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011969","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000}}],"reference-count":148,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011969.pub2","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T20:52:29Z","timestamp":1489697549000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Deprescribing versus continuation of chronic proton pump inhibitor use in adults"],"prefix":"10.1002","volume":"2017","author":[{"given":"Taline A","family":"Boghossian","sequence":"first","affiliation":[{"name":"The Ottawa Hospital; Department of Pharmacy; 501 Smyth Road Ottawa ON Canada K1H 8L6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah Joy","family":"Rashid","sequence":"additional","affiliation":[{"name":"The Ottawa Hospital; Department of Pharmacy; 501 Smyth Road Ottawa ON Canada K1H 8L6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade","family":"Thompson","sequence":"additional","affiliation":[{"name":"University of Ottawa; Bruy\u00e8re Research Institute; 43 rue Bruyere St Room 730D Ottawa ON Canada K1N 5C8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Welch","sequence":"additional","affiliation":[{"name":"University of Ottawa; Bruy\u00e8re Research Institute; 43 rue Bruyere St Room 730D Ottawa ON Canada K1N 5C8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[{"name":"McMaster University; Department of Medicine, Division of Gastroenterology; 1200 Main Street West Room 4W8E Hamilton ON Canada L8N 3Z5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rojas-Fernandez","sequence":"additional","affiliation":[{"name":"University of Waterloo; School of Pharmacy; 10 Victoria St S. Room 7004 Kitchener ON Canada N2G 1C5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pottie","sequence":"additional","affiliation":[{"name":"University of Ottawa; Bruy\u00e8re Research Institute; 43 rue Bruyere St Room 730D Ottawa ON Canada K1N 5C8"},{"name":"University of Ottawa; Family Medicine; 75 Bruyere St Ottawa ON Canada K1N 5C8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Farrell","sequence":"additional","affiliation":[{"name":"University of Ottawa; Bruy\u00e8re Research Institute; 43 rue Bruyere St Room 730D Ottawa ON Canada K1N 5C8"},{"name":"University of Waterloo; School of Pharmacy; 10 Victoria St S. Room 7004 Kitchener ON Canada N2G 1C5"},{"name":"University of Ottawa; Family Medicine; 75 Bruyere St Ottawa ON Canada K1N 5C8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"issue":"48","key":"10.1002\/14651858.CD011969.pub2-BIB0001|cit1","first-page":"1","article-title":"Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease","volume":"16","author":"Bayerd\u00f6rffer","year":"2016","journal-title":"BMC Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2005.02413.x","article-title":"Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment","volume":"21","author":"Bour","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.curtheres.2005.08.012","article-title":"Effects of pantoprazole 20 mg in mild gastroesophageal reflux disease: once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term","volume":"66","author":"Janssen","year":"2005","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"12","key":"10.1002\/14651858.CD011969.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1155\/2007\/203201","article-title":"Maintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg","volume":"21","author":"Morgan","year":"2007","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD011969.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1365-2036.2003.01593.x","article-title":"Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole","volume":"17","author":"Pilotto","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000236025","article-title":"Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial","volume":"81","author":"Velden","year":"2010","journal-title":"Digestion"},{"issue":"21","key":"10.1002\/14651858.CD011969.pub2-BIB0007|cit7","first-page":"742","article-title":"Omeprazole in patient with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment","volume":"45","author":"Annibale","year":"1998","journal-title":"Hepato-Gastroenterology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD011969.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/0016-5085(88)90003-0","article-title":"Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief","volume":"94","author":"Archambault","year":"1988","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0009|cit9","first-page":"20","article-title":"Omeprazole or ranitidine for reflux oesophagitis: comment","volume":"3","author":"Bardhan","year":"1990","journal-title":"National Medical Journal of India"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2036.1995.tb00363.x","article-title":"Lansoprazole versus ranitidine for the treatment of reflux oesophagitis","volume":"9","author":"Bardhan","year":"1995","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD011969.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gut.30.10.1323","article-title":"Randomized, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer","volume":"30","author":"Bate","year":"1989","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.31.9.968","article-title":"Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic and histological evaluations","volume":"31","author":"Bate","year":"1990","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/gut.36.4.492","article-title":"Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis","volume":"36","author":"Bate","year":"1995","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2036.1997.00198.x","article-title":"Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis","volume":"11","author":"Bate","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD011969.pub2-BIB0015|cit15","first-page":"S112","article-title":"The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: what is the evidence?","volume":"21","author":"Bautista","year":"2006","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"196","key":"10.1002\/14651858.CD011969.pub2-BIB0016|cit16","first-page":"19","article-title":"Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin","volume":"28","author":"Bayerd\u00f6rffer","year":"1992","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2036.2005.02637.x","article-title":"Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg","volume":"22","author":"Bigard","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","article-title":"Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial","volume":"24","author":"Bj\u00f6rnsson","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2036.2004.01999.x","article-title":"Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease","volume":"20","author":"Bytzer","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","article-title":"Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole","volume":"10","author":"Carlsson","year":"1998","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD011969.pub2-BIB0021|cit21","first-page":"538","article-title":"Study on omeprazole 20 mg twice weekly in prevention of duodenal ulcer relapse","volume":"32","author":"Chen","year":"1993","journal-title":"Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine]"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2010.04519.x","article-title":"The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease","volume":"33","author":"Dabholkar","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF03002423","article-title":"Lansoprazole 15 mg OD is superior to ranitidine 300 mg OD in relieving heartburn and healing patients with (endoscopically confirmed) reflux oesophagitis grade I","volume":"33","author":"Deboever","year":"2003","journal-title":"Acta Endoscopica"},{"issue":"166","key":"10.1002\/14651858.CD011969.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/00365528909091249","article-title":"Evaluation of omeprazole in reflux oesophagitis","volume":"24","author":"Dent","year":"1989","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/gut.35.5.590","article-title":"Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety","volume":"35","author":"Dent","year":"1994","journal-title":"Gut"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cgh.2006.03.006","article-title":"Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams","volume":"4","author":"DeVault","year":"2006","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1572-0241.1998.00238.x","article-title":"A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis","volume":"93","author":"Earnest","year":"1998","journal-title":"American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1365-2036.2009.03948.x","article-title":"Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care - prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg","volume":"29","author":"Eggleston","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD011969.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1365-2036.1999.00651.x","article-title":"Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis","volume":"13","author":"Escourrou","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD011969.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1572-0241.2000.02233.x","article-title":"Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial","volume":"95","author":"Farley","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ajg.2010.458","article-title":"The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD","volume":"106","author":"Fass","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cgh.2011.11.021","article-title":"Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release","volume":"10","author":"Fass","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.2009.04064.x","article-title":"Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects","volume":"30","author":"Fennerty","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1440-1746.1995.tb01055.x","article-title":"Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: a randomized double-blind, placebo-controlled study","volume":"10","author":"Goh","year":"1995","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MEG.0b013e32801055d5","article-title":"Efficacy of pantoprazole 20mg daily compared with esomeprazole 20mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study","volume":"19","author":"Goh","year":"2007","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.1996.14156000.x","article-title":"Lansoprazole versus ranitidine in the maintenance treatment reflux oesophagitis","volume":"10","author":"Gough","year":"1996","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2036.1997.144320000.x","article-title":"Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis","volume":"11","author":"Hatlebakk","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1365-2036.1997.00246.x","article-title":"Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole","volume":"11","author":"Hatlebakk","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6515","key":"10.1002\/14651858.CD011969.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.296.6615.89","article-title":"Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial","volume":"296","author":"Havelund","year":"1988","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011969.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/00004836-199506002-00019","article-title":"Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?","volume":"20","author":"Hoshino","year":"1995","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1572-0241.2001.03861.x","article-title":"Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies","volume":"96","author":"Howden","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2036.2009.04119.x","article-title":"Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief","volume":"30","author":"Howden","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cgh.2014.09.033","article-title":"Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis","volume":"13","author":"Hsu","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1053\/gast.2001.28649","article-title":"Step-down management of gastroesophageal reflux disease","volume":"121","author":"Inadomi","year":"2001","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1572-0241.2003.07665.x","article-title":"Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPI","volume":"98","author":"Inadomi","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ageing\/23.2.121","article-title":"Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis","volume":"23","author":"James","year":"1994","journal-title":"Age and Ageing"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1572-0241.2001.03443.x","article-title":"Esomeprazole once daily for 6 months Is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"96","author":"Johnson","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2036.2010.04339.x","article-title":"Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances","volume":"32","author":"Johnson","year":"2010","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2036.1997.00179.x","article-title":"Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice","volume":"11","author":"Jones","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2036.2008.03877.x","article-title":"On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor","volume":"29","author":"Juul-Hansen","year":"2008","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archfami.9.7.624","article-title":"Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia","volume":"9","author":"Kaplan-Machlis","year":"2000","journal-title":"Archives of Family Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00042737-200509000-00009","article-title":"Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease","volume":"17","author":"Kaspari","year":"2005","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"8529","key":"10.1002\/14651858.CD011969.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(87)91726-0","article-title":"Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis","volume":"1","author":"Klinkenberg-Knol","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10620-009-0871-8","article-title":"Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole","volume":"55","author":"Kovacs","year":"2010","journal-title":"Digestive Diseases and Sciences"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2036.2005.02643.x","article-title":"Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study","volume":"22","author":"Labenz","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2036.2003.01464.x","article-title":"Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results","volume":"17","author":"Lauritsen","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-2036.1999.00564.x","article-title":"On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - a placebo-controlled randomized trial","volume":"13","author":"Lind","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/00365529109025038","article-title":"Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine","volume":"26","author":"Lundell","year":"1991","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2036.2003.01410.x","article-title":"Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis","volume":"17","author":"Metz","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00365521.2013.878380","article-title":"A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan","volume":"49","author":"Nagahara","year":"2014","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/ajg.2010.81","article-title":"Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial","volume":"105","author":"Niklasson","year":"2010","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1368-5031.2005.00564.x","article-title":"A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease","volume":"59","author":"Norman Hansen","year":"2005","journal-title":"International Journal of Clinical Practice"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.2009.04064.x","article-title":"Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects","volume":"30","author":"Peura","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00325481.2016.1203236","article-title":"A 14-day regimen of esomeprazole 20 mg\/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction","volume":"128","author":"Peura","year":"2016","journal-title":"Postgraduate Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1023\/B:DDAS.0000034551.39324.c3","article-title":"On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction","volume":"49","author":"Ponce","year":"2004","journal-title":"Digestive Diseases and Sciences"},{"issue":"10","key":"10.1002\/14651858.CD011969.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/MEG.0b013e32833d56d1","article-title":"Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse","volume":"22","author":"Reimer","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD011969.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2000.03254.x","article-title":"Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial","volume":"95","author":"Richter","year":"2000","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2036.2004.02121.x","article-title":"Prevention of erosive oesophagitis relapse with pantoprazole","volume":"20","author":"Richter","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.1995.tb00347.x","article-title":"A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis","volume":"9","author":"Robinson","year":"1995","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/00365528809093923","article-title":"Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study","volume":"23","author":"Sandmark","year":"1988","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"2-3","key":"10.1002\/14651858.CD011969.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000087661","article-title":"On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial","volume":"72","author":"Scholten","year":"2005","journal-title":"Digestion"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2036.2005.02553.x","article-title":"Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis","volume":"22","author":"Sj\u00f6stedt","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.1997.141317000.x","article-title":"Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study","volume":"11","author":"Sontag","year":"1997","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"22","key":"10.1002\/14651858.CD011969.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.3748\/wjg.v21.i22.6965","article-title":"Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis","volume":"21","author":"Sun","year":"2015","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2036.2001.00943.x","article-title":"Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months","volume":"15","author":"Talley","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5694\/j.1326-5377.2002.tb04882.x","article-title":"Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care","volume":"117","author":"Talley","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"10.1002\/14651858.CD011969.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00042737-200208000-00008","article-title":"Esomeprazole 40 mg and 20 mg is efficacious in the long term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months","volume":"14","author":"Talley","year":"2002","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00535-011-0402-1","article-title":"Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial","volume":"46","author":"Tan","year":"2011","journal-title":"Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2004.02155.x","article-title":"Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study","volume":"20","author":"Tsai","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1365-2036.2001.01024.x","article-title":"The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"Vakil","year":"2001","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01311234","article-title":"U.S. experience with omeprazole in duodenal ulcer-multicenter double-blind comparative study with ranitidine","volume":"36","author":"Valenzuela","year":"1991","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.0953-0673.1996.00397.x","article-title":"Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux esophagitis","volume":"10","author":"Rensburg","year":"1996","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1185\/03007990802184545","article-title":"Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia","volume":"24","author":"Rensburg","year":"2008","journal-title":"Current Medical Research and Opinion"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF01798351","article-title":"Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis","volume":"33","author":"Vantrappen","year":"1988","journal-title":"Digestive Diseases and Sciences"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00042737-200012020-00011","article-title":"Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study","volume":"12","author":"Zyl","year":"2000","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/00365529709011211","article-title":"Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice","volume":"32","author":"Venables","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"17","key":"10.1002\/14651858.CD011969.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"6674","key":"10.1002\/14651858.CD011969.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.298.6674.645","article-title":"Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial","volume":"298","author":"Danish Omeprazole Study Group","year":"1989","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0089|cit89","doi-asserted-by":"crossref","unstructured":"Zwisler JE Jarbol DE Lassen AT Kragstrup J Thorsgaard N Schaffalitzky de Muckadell OB Placebo-controlled discontinuation of long-term acid-suppressant therapy: a randomised trial in general practice International Journal of Family Medicine 2015 175436 10.1155\/2015\/175436","DOI":"10.1155\/2015\/175436"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0090|cit90","unstructured":"Alberta Clinical Practice Guideline Working Group Guideline for diagnosis and treatment of chronic undiagnosed dyspepsia in adults The Alberta Clinical Guideline Program 2000 1 10"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0091|cit91","first-page":"66","article-title":"Reducing adverse effects of proton pump inhibitors","volume":"86","author":"Ament","year":"2012","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2296-11-65","article-title":"Qualitative insights into general practitioners views on polypharmacy","volume":"11","author":"Anthierens","year":"2010","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0093|cit93","doi-asserted-by":"crossref","unstructured":"Armstrong TA Coursin DB Devlin J Duke JS Fish D Gonzalez ER ASHP therapeutic guidelines on stress ulcer prophylaxis American Journal of Health-System Pharmacy 1999 347 79","DOI":"10.1093\/ajhp\/56.4.347"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2005\/836030","article-title":"Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004","volume":"19","author":"Armstrong","year":"2005","journal-title":"Canadian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0095|cit95","unstructured":"Canadian Agency for Drugs and Technologies in Health Economic models and conclusions for the treatment of dyspepsia; and gastroesophageal reflux disease-related heartburn and the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal complications, 2007 www.cadth.ca\/sites\/default\/files\/compus\/pdf\/compus_economic_report_april-07_e.pdf"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0096|cit96","unstructured":"Canadian Digestive Health Foundation GERD, 2015 www.cdhf.ca\/en\/statistics"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0097|cit97","unstructured":"Canadian Healthcare Network Top 100 Drugs Pharmacy Practice 2013 1 25"},{"issue":"11","key":"10.1002\/14651858.CD011969.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/SMJ.0b013e31826efbea","article-title":"Proton pump inhibitors: the good, the bad, and the unwanted","volume":"105","author":"Chubineh","year":"2012","journal-title":"Southern Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjopharm.2008.12.001","article-title":"Appropriate proton pump inhibitor use among older adults: a retrospective chart review","volume":"6","author":"Claudene","year":"2008","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0100|cit100","first-page":"21","article-title":"Assessing the appropriate use of proton pump inhibitors in a veteran outpatient population","volume":"30","author":"Dangler","year":"2013","journal-title":"Federal Practitioner"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/gut.2004.051821","article-title":"Epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"54","author":"Dent","year":"2005","journal-title":"Gut"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Dersimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0103|cit103","doi-asserted-by":"crossref","unstructured":"Donnellan C Preston C Moayyedi P Sharma N Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease Cochrane Database of Systematic Reviews 2004 CD003245 10.1002\/14651858.CD003245.pub2","DOI":"10.1002\/14651858.CD003245.pub2"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4292\/wjgpt.v2.i3.17","article-title":"Proton pump inhibitor-associated pneumonia: not a breath of fresh air after all?","volume":"2","author":"Fohl","year":"2011","journal-title":"World Journal of Gastrointestinal Pharmacology and Therapeutics"},{"issue":"7634","key":"10.1002\/14651858.CD011969.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Overprescribing proton pump inhibitors","volume":"336","author":"Forgacs","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1111\/j.1445-5994.2010.02259.x","article-title":"Initiation and duration of proton pump inhibitors in the Australian veteran population","volume":"42","author":"Gadzhanova","year":"2012","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0107|cit107","first-page":"10","volume-title":"Gastro-oesophageal Reflux Disease in Adults","author":"Gastroenterological Society of Australia","year":"2011"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2036.2004.01898.x","article-title":"Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer","volume":"19","author":"Gisbert","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cger.2012.01.006","article-title":"Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes","volume":"28","author":"Gnjidic","year":"2012","journal-title":"Clinics in Geriatric Medicine"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0110|cit110","unstructured":"GRADE Working Group, McMaster University GRADEpro 2014"},{"issue":"19","key":"10.1002\/14651858.CD011969.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.1997.00440400055007","article-title":"Adverse events after discontinuing medications in elderly outpatients","volume":"157","author":"Graves","year":"1997","journal-title":"Archives of Internal Medicine"},{"issue":"470","key":"10.1002\/14651858.CD011969.pub2-BIB0112|cit112","first-page":"703","article-title":"Proton pump inhibitors: perspectives of patients and their GPs","volume":"51","author":"Grime","year":"2001","journal-title":"British Journal of General Practice"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/fampra\/cmu050","article-title":"Strategies for discontinuation of proton pump inhibitors: a systematic review","volume":"31","author":"Haastrup","year":"2014","journal-title":"Family Practice"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0114|cit114","first-page":"e228","article-title":"Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting","volume":"16","author":"Heidelbaugh","year":"2010","journal-title":"American Journal of Managed Care"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0115|cit115","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.2008.224","article-title":"The effects of polypharmacy in older adults","volume":"85","author":"Hilmer","year":"2009","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0117|cit117","doi-asserted-by":"crossref","unstructured":"Iyer S Naganathan V McLachlan AJ Le Couteur DG Medication withdrawal trials in people aged 65 years and older: a systematic review Drugs and Aging 2008 1021 31","DOI":"10.2165\/0002512-200825120-00004"},{"issue":"125","key":"10.1002\/14651858.CD011969.pub2-BIB0118|cit118","first-page":"1077","article-title":"Maintenance treatment of mild gastroesophageal reflux disease with proton pump inhibitors taken on-demand: a meta-analysis","volume":"60","author":"Jiang","year":"2013","journal-title":"Hepato-gastroenterology"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0119|cit119","doi-asserted-by":"crossref","unstructured":"Katz PO Gerson LB Vela MF Guidelines for the diagnosis and management of gastroesophageal reflux disease American Journal of Gastroenterology 2013 308 28","DOI":"10.1038\/ajg.2012.444"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2011.480","article-title":"Management of patients with ulcer bleeding","volume":"107","author":"Laine","year":"2012","journal-title":"American Journal of Gastroenterology"},{"issue":"11-12","key":"10.1002\/14651858.CD011969.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1365-2036.2004.02289.x","article-title":"Systematic review: is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?","volume":"20","author":"Lee","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/SMJ.0b013e31828db01f","article-title":"Four-year trends of inappropriate proton pump inhibitor use after hospital discharge","volume":"106","author":"Leri","year":"2013","journal-title":"Southern Medical Association"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamainternmed.2013.4068","article-title":"Reversing gears: discontinuing medication therapy to prevent adverse events","volume":"173","author":"Linsky","year":"2013","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011969.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"issue":"9699","key":"10.1002\/14651858.CD011969.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(09)60938-7","article-title":"Peptic ulcer disease","volume":"374","author":"Malfertheiner","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11845-009-0426-1","article-title":"Inappropriate use of proton pump inhibitors","volume":"179","author":"Molloy","year":"2010","journal-title":"Irish Journal of Medical Science"},{"issue":"8","key":"10.1002\/14651858.CD011969.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1592\/phco.28.8.968","article-title":"Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit","volume":"28","author":"Murphy","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2036.2005.02558.x","article-title":"Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease","volume":"22","author":"Pace","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11938-008-0005-y","article-title":"On-demand PPI therapy in GERD","volume":"11","author":"Pace","year":"2008","journal-title":"Current Treatment Options in Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000089727","article-title":"Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners","volume":"72","author":"Raghunath","year":"2005","journal-title":"Digestion"},{"issue":"11","key":"10.1002\/14651858.CD011969.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40266-012-0024-1","article-title":"Difficulties reducing inappropriate prescribing of proton pump inhibitors in the elderly","volume":"29","author":"Reeve","year":"2012","journal-title":"Drugs & Aging"},{"issue":"10","key":"10.1002\/14651858.CD011969.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: a systematic review","volume":"30","author":"Reeve","year":"2013","journal-title":"Drugs & Aging"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1060028014558290","article-title":"Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors","volume":"49","author":"Reeve","year":"2015","journal-title":"Annals of Pharmacotherapy"},{"issue":"7","key":"10.1002\/14651858.CD011969.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2036.2009.04092.x","article-title":"Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients","volume":"30","author":"Reimer","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2009.03.058","article-title":"Proton-pump inhibitor therapy induces acid-related symptoms in health volunteers after withdrawal of therapy","volume":"137","author":"Reimer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0136|cit136","unstructured":"The Nordic Cochrane Centre: The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/eb-2012-100930","article-title":"Deciding when to stop: towards evidence-based deprescribing of drugs in older populations","volume":"18","author":"Scott","year":"2013","journal-title":"Evidence-Based Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011969.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4037\/ccn2006.26.1.18","article-title":"Update on stress ulcer prophylaxis in critically ill patients","volume":"26","author":"Spirt","year":"2006","journal-title":"Critical Care Nurse"},{"issue":"10","key":"10.1002\/14651858.CD011969.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","article-title":"Guidelines for the management of dyspepsia","volume":"100","author":"Talley","year":"2005","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011969.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4212\/cjhp.v66i3.1261","article-title":"Deprescribing: what is it and what does the evidence tell us?","volume":"66","author":"Thompson","year":"2013","journal-title":"Canadian Journal of Hospital Pharmacy"},{"issue":"10","key":"10.1002\/14651858.CD011969.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/j.1572-0241.1999.01427.x","article-title":"Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study","volume":"94","author":"Tougas","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD011969.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011969.pub2-BIB0143|cit143","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010455.pub2","article-title":"Down-titration and discontinuation strategies of tumor necrosis factor\u2013blocking agents for rheumatoid arthritis in patients with low disease activity","author":"Herwaarden","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011969.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1155\/2005\/674607","article-title":"Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool","volume":"19","author":"Veldhuyzen van Zanten","year":"2005","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD011969.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s11096-012-9681-8","article-title":"Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria","volume":"34","author":"Wahab","year":"2012","journal-title":"International Journal of Clinical Pharmacy"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0146|cit146","first-page":"1309","article-title":"Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Wallace","year":"2011"},{"key":"10.1002\/14651858.CD011969.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1365-2036.2005.02490.x","article-title":"Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients","volume":"21","author":"Zacny","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD011969.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.gerinurse.2011.06.002","article-title":"The challenge of discontinuing proton pump inhibitors","volume":"32","author":"Zarowitz","year":"2011","journal-title":"Geriatric Nursing"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011969.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T03:33:00Z","timestamp":1703647980000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011969.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":148,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011969.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}